Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LIFE exchanges : Nasdaq save search
aTyr Pharma to Participate in April Investor Conferences
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: -3.05%
pharma
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.0%
H: 24.07%
C: 22.84%
pharma year update results
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: -5.0%
pharma conference year financial results
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
Published: 2024-02-21 (Crawled : 13:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 1.6%
H: 5.24%
C: 3.14%
pharma program trial
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.0%
H: 3.16%
C: 2.53%
pharma cell
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
Published: 2024-01-18 (Crawled : 13:00) - globenewswire.com
WDAY S | $252.12 -1.38% -1.4% 1.5M
|
Technology Services
|
| O: 0.71%
H: 0.87%
C: 0.84%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 0.95%
H: 0.87%
C: 0.54%
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: -4.05%
pharma
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -1.79%
H: 6.36%
C: 1.36%
pharma preclinical efzofitimod
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.87%
H: 0.86%
C: -3.45%
pharma update results
Sarcoidosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Key Players - Pfizer, United Therapeutics, Xentria, aTyr Pharma, Kyorin Pharmaceutical, Novartis, Kinevant Sciences
Published: 2023-11-02 (Crawled : 21:00) - prnewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.73%
H: 0.63%
C: -2.35%
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.78%
H: 1.54%
C: 0.0%
sciences growth market
aTyr Pharma to Present at November Investor Conferences
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 5.6%
H: 0.0%
C: -6.82%
pharma
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILDMultiple centers in the U.S. are open for enrollment
Published: 2023-10-31 (Crawled : 15:00) - biospace.com/
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -0.8%
H: 2.42%
C: 0.81%
pharma efzofitimod study
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -0.8%
H: 2.42%
C: 0.81%
pharma efzofitimod study phase 2
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
Published: 2023-09-11 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -1.2%
H: 2.44%
C: 1.22%
pharma efzofitimod
Lisa Carey
Published: 2023-08-24 (Crawled : 19:00) - atyrpharma.com
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 0.85%
H: 0.42%
C: -11.39%
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.0%
H: 3.26%
C: 0.54%
ADXS | $0.57 12.48% 9.5K
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: -4.76%
aTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-08-24 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.27%
H: 0.54%
C: 0.0%
pharma conference global
aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
Published: 2023-08-09 (Crawled : 20:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 1.02%
H: 1.01%
C: -1.01%
pharma update results
Corporate Communications Intern
Published: 2023-08-08 (Crawled : 17:00) - atyrpharma.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -0.51%
H: 1.28%
C: 0.0%
communications
Research Associate, In Vitro Biology
Published: 2023-06-22 (Crawled : 16:00) - atyrpharma.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 1.3%
H: 0.39%
C: -2.99%
research in vitro
European Commission Grants Orphan Drug Designation for aTyr Pharma’s Efzofitimod for Treatment of Systemic Sclerosis
Published: 2023-06-22 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 1.3%
H: 0.39%
C: -2.99%
drug sclerosis treatment designation grants efzofitimod
aTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
Published: 2023-06-20 (Crawled : 12:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: -4.51%
pharma candidate conference association efzofitimod
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.